Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,223,438 papers from all fields of science
Search
Sign In
Create Free Account
NGX-4010
Known as:
NGX 4010
, NGX4010
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Capsaicin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
F1000Prime recommendation of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
J. Kilby
2013
Corpus ID: 88283850
2011
2011
NEUROPATHIC PAIN SECTION Original Research Articles A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic…
G. Irving
,
M. Backonja
,
E. Dunteman
,
E. Blonsky
,
G. Vanhove
,
J. Tobias
2011
Corpus ID: 116056561
Objectives. To confirm the efficacy, tolerability, and safety of NGX-4010, an 8% capsaicin dermal patch
Review
2010
Review
2010
Medicolegal Issues 77 . Stolen prescription medical reports part 2 : still cause for alarm
Pain MANAGEMENT’S
2010
Corpus ID: 17645004
Cultural Aspects of Pain 3. BMI levels and pain indices in Hispanics with chronic pain 4. Typology of chronic pain among…
Expand
2005
2005
NGX 4010 may reduce HIV-associated sensory neuropathy
2005
Corpus ID: 195138981
2004
2004
NGX MIJOQRLFMIRNNV [ MUF QGSL GIU UJ UFRU SLRIG Y dJ MKLNGK GHU UFG NJJL UQRHSPJQK RUMJH T JHG K^SU OGHGQRUG R NJJL HGSU UJ SIRH UFG MUGQRUMJHS MH UFG UQRHSPJQK GW MUGQRUMJH SLRIG MH NGX MIJOQRLFMI
Ijklmnmho Pjq
,
Lrqrnngn K Rifmhgs
,
+9 authors
Jqwgq Y dFMS
2004
Corpus ID: 14582864
E FGH IJKLMNMHO PJQ LRQRNNGN K RIFMHGS T MU MS JPUGH HGIGSSRQV UJ OGHGQRUG R NJJL HGSU UJ SIRH R QGOMJH JP MHWGX LJMHUS MH NGX…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE